| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
| filingDate |
1999-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100311857-B1 |
| titleOfInvention |
Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| abstract |
The present invention relates to a synthetic polysaccharide, a preparation method thereof and a pharmaceutical composition comprising the same.n n n It comprises antithrombin III capable of binding to a region consisting of a series of five monosaccharides having a total of two carboxylic acid functional groups and at least four sulfo groups, wherein the region is independently a hydroxyl group (C 1 − C 6 ) by a thrombin-binding region comprising a series of 10 to 25 monosaccharide units selected from hexose, pentose or deoxy sugars which can be etherified with alkyl groups or esterified in the form of sulfo groups It is characterized by describing synthetic polysaccharides and their pharmaceutically acceptable salts which bind directly at their unreduced ends. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011093573-A1 |
| priorityDate |
1996-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |